Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 50
Filter
1.
Am J Transplant ; 17(1): 140-150, 2017 01.
Article in English | MEDLINE | ID: mdl-27333454

ABSTRACT

The Banff working group on preimplantation biopsy was established to develop consensus criteria (best practice guidelines) for the interpretation of preimplantation kidney biopsies. Digitally scanned slides were used (i) to evaluate interobserver variability of histopathologic findings, comparing frozen sections with formalin-fixed, paraffin-embedded tissue of wedge and needle core biopsies, and (ii) to correlate consensus histopathologic findings with graft outcome in a cohort of biopsies from international medical centers. Intraclass correlations (ICCs) and univariable and multivariable statistical analyses were performed. Good to fair reproducibility was observed in semiquantitative scores for percentage of glomerulosclerosis, arterial intimal fibrosis and interstitial fibrosis on frozen wedge biopsies. Evaluation of frozen wedge and core biopsies was comparable for number of glomeruli, but needle biopsies showed worse ICCs for glomerulosclerosis, interstitial fibrosis and tubular atrophy. A consensus evaluation form is provided to help standardize the reporting of histopathologic lesions in donor biopsies. It should be recognized that histologic parameters may not correlate with graft outcome in studies based on organs deemed to be acceptable after careful clinical assessment. Significant limitations remain in the assessment of implantation biopsies.


Subject(s)
Kidney Transplantation , Kidney/pathology , Kidney/surgery , Tissue Donors , Biopsy, Needle , Consensus , Humans
2.
Am J Transplant ; 17(1): 28-41, 2017 01.
Article in English | MEDLINE | ID: mdl-27862883

ABSTRACT

The XIII Banff meeting, held in conjunction the Canadian Society of Transplantation in Vancouver, Canada, reviewed the clinical impact of updates of C4d-negative antibody-mediated rejection (ABMR) from the 2013 meeting, reports from active Banff Working Groups, the relationships of donor-specific antibody tests (anti-HLA and non-HLA) with transplant histopathology, and questions of molecular transplant diagnostics. The use of transcriptome gene sets, their resultant diagnostic classifiers, or common key genes to supplement the diagnosis and classification of rejection requires further consensus agreement and validation in biopsies. Newly introduced concepts include the i-IFTA score, comprising inflammation within areas of fibrosis and atrophy and acceptance of transplant arteriolopathy within the descriptions of chronic active T cell-mediated rejection (TCMR) or chronic ABMR. The pattern of mixed TCMR and ABMR was increasingly recognized. This report also includes improved definitions of TCMR and ABMR in pancreas transplants with specification of vascular lesions and prospects for defining a vascularized composite allograft rejection classification. The goal of the Banff process is ongoing integration of advances in histologic, serologic, and molecular diagnostic techniques to produce a consensus-based reporting system that offers precise composite scores, accurate routine diagnostics, and applicability to next-generation clinical trials.


Subject(s)
Arteritis/immunology , Complement C4b/immunology , Graft Rejection/classification , Graft Rejection/pathology , Isoantibodies/immunology , Kidney Transplantation/adverse effects , Peptide Fragments/immunology , Graft Rejection/etiology , Humans , Research Report
3.
Oncogene ; 35(25): 3282-92, 2016 06 23.
Article in English | MEDLINE | ID: mdl-26477312

ABSTRACT

Despite recent insights into prostate cancer (PCa)-associated genetic changes, full understanding of prostate tumorigenesis remains elusive owing to complexity of interactions among various cell types and soluble factors present in prostate tissue. We found the upregulation of nuclear factor of activated T cells c1 (NFATc1) in human PCa and cultured PCa cells, but not in normal prostates and non-tumorigenic prostate cells. To understand the role of NFATc1 in prostate tumorigenesis in situ, we temporally and spatially controlled the activation of NFATc1 in mouse prostate and showed that such activation resulted in prostatic adenocarcinoma with features similar to those seen in human PCa. Our results indicate that the activation of a single transcription factor, NFATc1 in prostatic luminal epithelium to PCa can affect expression of diverse factors in both cells harboring the genetic changes and in neighboring cells through microenvironmental alterations. In addition to the activation of oncogenes c-MYC and STAT3 in tumor cells, a number of cytokines and growth factors, such as IL1ß, IL6 and SPP1 (osteopontin, a key biomarker for PCa), were upregulated in NFATc1-induced PCa, establishing a tumorigenic microenvironment involving both NFATc1 positive and negative cells for prostate tumorigenesis. To further characterize interactions between genes involved in prostate tumorigenesis, we generated mice with both NFATc1 activation and Pten inactivation in prostate. We showed that NFATc1 activation led to acceleration of Pten null-driven prostate tumorigenesis by overcoming the PTEN loss-induced cellular senescence through inhibition of p21 activation. This study provides direct in vivo evidence of an oncogenic role of NFATc1 in prostate tumorigenesis and reveals multiple functions of NFATc1 in activating oncogenes, in inducing proinflammatory cytokines, in oncogene addiction, and in overcoming cellular senescence, which suggests calcineurin-NFAT signaling as a potential target in preventing PCa.


Subject(s)
Cell Transformation, Neoplastic/genetics , NFATC Transcription Factors/genetics , Prostate/metabolism , Prostatic Neoplasms/genetics , Animals , Blotting, Western , Cell Line , Cell Line, Tumor , Cell Proliferation/genetics , Cell Transformation, Neoplastic/metabolism , Cellular Senescence/genetics , Cytokines/genetics , Cytokines/metabolism , Gene Expression Regulation, Neoplastic , Humans , Immunohistochemistry , Male , Mice, Knockout , Mice, Nude , Mice, Transgenic , NFATC Transcription Factors/metabolism , PTEN Phosphohydrolase/genetics , PTEN Phosphohydrolase/metabolism , Prostatic Neoplasms/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Transplantation, Homologous , Tumor Cells, Cultured , Tumor Microenvironment/genetics
4.
Am J Transplant ; 14(2): 272-83, 2014 Feb.
Article in English | MEDLINE | ID: mdl-24472190

ABSTRACT

The 12th Banff Conference on Allograft Pathology was held in Comandatuba, Brazil, from August 19-23, 2013, and was preceded by a 2-day Latin American Symposium on Transplant Immunobiology and Immunopathology. The meeting was highlighted by the presentation of the findings of several working groups formed at the 2009 and 2011 Banff meetings to: (1) establish consensus criteria for diagnosing antibody-mediated rejection (ABMR) in the presence and absence of detectable C4d deposition; (2) develop consensus definitions and thresholds for glomerulitis (g score) and chronic glomerulopathy (cg score), associated with improved inter-observer agreement and correlation with clinical, molecular and serological data; (3) determine whether isolated lesions of intimal arteritis ("isolated v") represent acute rejection similar to intimal arteritis in the presence of tubulointerstitial inflammation; (4) compare different methodologies for evaluating interstitial fibrosis and for performing/evaluating implantation biopsies of renal allografts with regard to reproducibility and prediction of subsequent graft function; and (5) define clinically and prognostically significant morphologic criteria for subclassifying polyoma virus nephropathy. The key outcome of the 2013 conference is defining criteria for diagnosis of C4d-negative ABMR and respective modification of the Banff classification. In addition, three new Banff Working Groups were initiated.


Subject(s)
Arteritis/etiology , Complement C4b/metabolism , Graft Rejection/etiology , Isoantibodies/immunology , Organ Transplantation/adverse effects , Peptide Fragments/metabolism , Arteritis/metabolism , Graft Rejection/metabolism , Humans , Research Report
5.
Am J Transplant ; 10(3): 464-71, 2010 Mar.
Article in English | MEDLINE | ID: mdl-20121738

ABSTRACT

The 10th Banff Conference on Allograft Pathology was held in Banff, Canada from August 9 to 14, 2009. A total of 263 transplant clinicians, pathologists, surgeons, immunologists and researchers discussed several aspects of solid organ transplants with a special focus on antibody mediated graft injury. The willingness of the Banff process to adapt continuously in response to new research and improve potential weaknesses, led to the implementation of six working groups on the following areas: isolated v-lesion, fibrosis scoring, glomerular lesions, molecular pathology, polyomavirus nephropathy and quality assurance. Banff working groups will conduct multicenter trials to evaluate the clinical relevance, practical feasibility and reproducibility of potential changes to the Banff classification. There were also sessions on quality improvement in biopsy reading and utilization of virtual microscopy for maintaining competence in transplant biopsy interpretation. In addition, compelling molecular research data led to the discussion of incorporation of omics-technologies and discovery of new tissue markers with the goal of combining histopathology and molecular parameters within the Banff working classification in the near future.


Subject(s)
Antibodies/chemistry , Organ Transplantation/methods , Biopsy , Canada , Complement C4b/metabolism , Fibrosis/pathology , Humans , Kidney Diseases/diagnosis , Kidney Diseases/pathology , Kidney Diseases/virology , Kidney Transplantation , Multicenter Studies as Topic , Peptide Fragments/metabolism , Phenotype , Polyomavirus Infections/diagnosis , Quality Control
6.
Am J Transplant ; 9(4): 812-9, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19344468

ABSTRACT

Diffuse peritubular capillary C4d deposition in renal allograft biopsies is associated with donor-specific antibodies (DSA) and graft failure. The significance of focal C4d+ is unclear. We reviewed 368 biopsies from 301 patients performed for renal dysfunction or proteinuria over 5 years. Diffuse C4d+, focal C4d+ and C4d- detected by immunofluorescence occurred in 9.5%, 20.9% and 69.4% of biopsies, respectively. Patients were similar in gender, age, cause of renal disease, donor source, HLA mismatch, serum creatinine at baseline and interval from transplantation to biopsy. Diffuse and focal C4d+ were associated with acute cellular rejection (p < 0.001). Transplant glomerulopathy was associated with diffuse C4d+. DSA at the time of biopsy, were positive in 79.3% of diffusely C4d+ patients, 68.8% of those with focal C4d+ (p = 0.27) and 9.9% of patients with C4d- (p < 0.001, compared to either the focal or diffuse groups, respectively). Allograft survival at 40 months was lower in diffuse C4d+ compared to the C4d- group (p = 0.014), but not when compared to the focal C4d+ group. There was a clear trend toward worse graft survival in patients with focal C4d+ in this time interval, but focal C4d+ compared to both diffuse C4d+ and C4d-groups was not statistically significant (p = 0.08).


Subject(s)
Complement C4b/analysis , Complement C4b/immunology , Graft Survival/immunology , Isoantibodies/blood , Kidney Transplantation/immunology , Peptide Fragments/analysis , Peptide Fragments/immunology , Tissue Donors , Transplantation, Homologous/immunology , Adult , Cadaver , Female , Humans , Kidney Transplantation/mortality , Living Donors/statistics & numerical data , Male , Middle Aged , Reoperation/statistics & numerical data , Retrospective Studies , Survival Analysis , Survivors , Tissue Donors/statistics & numerical data
7.
Am J Transplant ; 7(3): 518-26, 2007 Mar.
Article in English | MEDLINE | ID: mdl-17352710

ABSTRACT

The 8th Banff Conference on Allograft Pathology was held in Edmonton, Canada, 15-21 July 2005. Major outcomes included the elimination of the non-specific term "chronic allograft nephropathy" (CAN) from the Banff classification for kidney allograft pathology, and the recognition of the entity of chronic antibody-mediated rejection. Participation of B cells in allograft rejection and genomics markers of rejection were also major subjects addressed by the conference.


Subject(s)
Graft Rejection/diagnosis , Kidney Failure, Chronic/diagnosis , Kidney Transplantation , Antibodies/immunology , B-Lymphocytes/immunology , Chronic Disease , Diagnosis, Differential , Fibrosis , Genetic Markers , Graft Rejection/genetics , Graft Rejection/pathology , Humans , Kidney/immunology , Kidney/pathology , Kidney Failure, Chronic/genetics , Kidney Failure, Chronic/pathology , Organ Transplantation
8.
Ultrastruct Pathol ; 28(4): 181-97, 2004.
Article in English | MEDLINE | ID: mdl-15693630

ABSTRACT

Electron microscopy defined classic patterns of hereditary glomerular disease long before genetics revealed an underlying specific mutation. Genetic analysis is now easier to perform in clinical practice but an earlier optimism that genetics would predict disease severity and phenotype is challenged. The classic paradigm is Alport nephritis in which only a subset of mutations may predict glomerular abnormalities and disease severity. Interpretation of ultrastructural pathology of monogenetic diseases like Alport nephritis is complicated when the proband is the first family member to be diagnosed or there is discrepancy between clinical presentation and ultrastructural changes. In this review the authors have selected a dozen cases representative of common monogenetic glomerular diseases as a platform to discuss the utility of diagnostic electron microscopy in the era of molecular genetics. The emphasis is on genotype/glomerular phenotype correlations.


Subject(s)
Kidney Diseases/genetics , Kidney Diseases/pathology , Kidney Glomerulus/pathology , Kidney Glomerulus/ultrastructure , Microscopy, Electron, Transmission , Adolescent , Adult , Aged , Child, Preschool , Female , Genotype , Humans , Infant , Kidney Glomerulus/physiology , Male , Phenotype
10.
J Urol ; 166(4): 1433-8, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11547106

ABSTRACT

PURPOSE: We studied the long-term effects of complete unilateral ureteral obstruction on the extracellular matrix composition of the fetal kidney interstitium in neonatal opossums. MATERIALS AND METHODS: We created complete left ureteral obstruction in 2-week-old opossum pups. Sham operated animals served as controls. A total of 12 animals were sacrificed 2, 3 and 5 weeks after obstruction, and the kidneys were harvested. Resultant tissue sections were prepared for light and electron microscopy, and immunohistochemical testing for alpha-smooth muscle action (SMA), fibronectin, laminin and type IV collagen. In situ hybridization was done to determine interstitial collagen type I. Western blot analysis was performed on single kidney protein extracts for alpha-SMA, fibronectin and laminin. RESULTS: Light microscopy revealed established interstitial fibrosis and tubular atrophy 2 weeks after obstruction which increased with the duration of obstruction. Electron microscopy showed an increased number of interstitial fibroblasts, increased extracellular lucent substance and thin collagen fibrils. The tubular basement membranes were irregular and thickened compared with the continuous and even contours in controls. The deposition of alpha-SMA, fibronectin, collagen types I and type IV were markedly increased in the interstitium compared with controls and were highest at 5 weeks. Type IV collagen was associated with aberrant peritubular capillaries within the scarred interstitium. There were no appreciable differences in laminin expression in obstructed and sham operated kidneys. CONCLUSIONS: Experimental obstruction in opossums alters the cell phenotype, extracellular matrix and microcapillary composition in the fetal kidney interstitium. Biosynthetic properties of the interstitial fibroblasts in obstructed kidneys appear similar to those of undifferentiated mesenchyma before the induction of nephrons. We propose that these aberrant extracellular matrices coincident with cytoarchitectural disturbance may form a faulty scaffold that hampers normal kidney development secondary to complete unilateral ureteral obstruction.


Subject(s)
Extracellular Matrix , Kidney/embryology , Kidney/pathology , Ureteral Obstruction/metabolism , Animals , Animals, Newborn , Opossums
11.
Appl Immunohistochem Mol Morphol ; 9(2): 130-7, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11396630

ABSTRACT

Matrix metalloproteinases (MMPs) are proteolytic enzymes important at several points during multistep neoplastic progression. Although MMP-1 and MMP-3 have been implicated in the progression of various human cancers, their expression in bladder cancer has not been addressed. Immunohistochemistry (Strept-ABC-HRP method) and in situ hybridization were performed to detect MMP-1 protein, MMP-3 protein, and MMP-3 mRNA, respectively, in 59 transitional cell bladder carcinomas. To assess the role of these MMPs in bladder cancer, their expression was evaluated in relation to known clinicopathologic parameters and patients' disease-free and overall survival. Immunoreactivity for MMP-1 and MMP-3 proteins was observed in the cytoplasm of cancer cells in 30.5% and 24% of samples, respectively. Transcripts for MMP-3 mRNA were localized in stromal cells in 71.2% of cases and in cancer cells in 49% of cases. MMP-1 immunoreactivity demonstrated a statistically significant association with deeply invasive and grade III tumors versus superficial and lower grade tumors. MMP-3 protein immunoreactivity and MMP-3 mRNA immunolocalization did not associate with the parameters studied. However, MMP-3 mRNA localization in stromal cells demonstrated a borderline association with poor patients' disease-free and overall survival. In conclusion, the authors' results demonstrate a differential expression between MMP-1 and MMP-3 in bladder cancer; MMP-1 appears to participate in invasiveness and possibly in loss of differentiation in urothelial carcinomas in contrast to MMP-3.


Subject(s)
Carcinoma, Transitional Cell/enzymology , Matrix Metalloproteinase 1/metabolism , Matrix Metalloproteinase 3/metabolism , Urinary Bladder Neoplasms/enzymology , Adult , Aged , Aged, 80 and over , Carcinoma, Transitional Cell/metabolism , Carcinoma, Transitional Cell/mortality , Carcinoma, Transitional Cell/pathology , Disease-Free Survival , Female , Humans , Immunohistochemistry , In Situ Hybridization , Male , Matrix Metalloproteinase 1/genetics , Middle Aged , Neoplasm Invasiveness , Proportional Hazards Models , Stromal Cells/enzymology , Stromal Cells/metabolism , Survival Rate , Urinary Bladder/enzymology , Urinary Bladder/metabolism , Urinary Bladder/pathology , Urinary Bladder Neoplasms/metabolism , Urinary Bladder Neoplasms/mortality , Urinary Bladder Neoplasms/pathology
12.
Am J Physiol Renal Physiol ; 280(5): F777-85, 2001 May.
Article in English | MEDLINE | ID: mdl-11292619

ABSTRACT

Angiotensin II upregulates tumor necrosis factor-alpha (TNF-alpha) in the rat kidney with unilateral ureteral obstruction (UUO). In a mouse model of UUO, we found that tubulointerstitial fibrosis is blunted when the TNF-alpha receptor, TNFR1, is functionally knocked out. In this study, we used mutant mice with UUO in which the angiotensin II receptor AT(1a) or the TNF-alpha receptors TNFR1 and TNFR2 were knocked out to elucidate interactions between the two systems. The contribution of both systems to renal fibrosis was assessed by treating TNFR1/TNFR2-double knockout (KO) mice with an angiotensin-converting enzyme inhibitor, enalapril. The increased interstitial volume (Vv(int)) in the C57BI/6 wild-type mouse was decreased in the AT(1a) KO from 32.8 +/- 4.0 to 21.0 +/- 3.7% (P < 0.005) or in the TNFR1/TNFR2 KO to 22.3 +/- 2.1% (P < 0.005). The Vv(int) of the TNFR1/TNFR2 KO was further decreased to 15.2 +/- 3.7% (P < 0.01) by enalapril compared with no treatment. The induction of TNF-alpha mRNA and transforming growth factor-beta1 (TGF-beta1) mRNA in the kidney with UUO was significantly blunted in the AT(1a) or TNFR1/TNFR2 KO mice compared with the wild-type mice. Treatment of the TNFR1/TNFR2 KO mouse with enalapril reduced both TNF-alpha and TGF-beta1 mRNA and their proteins to near normal levels. Also, alpha-smooth muscle actin expression and myofibroblast proliferation were significantly inhibited in the AT(1a) or TNFR1/TNFR2 KO mice, and they were further inhibited in enalapril-treated TNFR1/TNFR2 KO mice. Incapacitating the angiotensin II or the TNF-alpha systems individually leads to partial blunting of fibrosis. Incapacitating both systems, by using a combination of genetic and pharmacological means, further inhibited interstitial fibrosis and tubule atrophy in obstructive nephropathy.


Subject(s)
Angiotensin II/physiology , Kidney/pathology , Tumor Necrosis Factor-alpha/physiology , Actins/biosynthesis , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Antigens, CD/genetics , Collagen/metabolism , Enalapril/pharmacology , Enzyme-Linked Immunosorbent Assay , Fibrosis , Kidney/ultrastructure , Lymphotoxin-alpha/physiology , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron , Muscle, Smooth/metabolism , RNA, Messenger/biosynthesis , Receptors, Tumor Necrosis Factor/genetics , Receptors, Tumor Necrosis Factor, Type I , Receptors, Tumor Necrosis Factor, Type II , Ureteral Obstruction/pathology
13.
Clin Cancer Res ; 7(2): 429-34, 2001 Feb.
Article in English | MEDLINE | ID: mdl-11234900

ABSTRACT

Multiple lines of evidence suggest that cyclooxygenase-2 (COX-2) is an important target for preventing epithelial malignancies. Little is known, however, about the expression of COX-2 in gynecological malignancies. By immunoblot analysis, COX-2 was detected in 12 of 13 cases of cervical cancer but was undetectable in normal cervical tissue. Immunohistochemistry revealed COX-2 in malignant epithelial cells. COX-2 was also expressed in cervical intraepithelial neoplasia. The mechanism by which COX-2 is up-regulated in cervical cancer is unknown. Because the epidermal growth factor (EGF) receptor is commonly overexpressed in cervical cancer, we investigated whether EGF could induce COX-2 in cultured human cervical carcinoma cells. Treatment with EGF markedly induced COX-2 protein, COX-2 mRNA, and stimulated COX-2 promoter activity. The induction of COX-2 by EGF was suppressed by inhibitors of tyrosine kinase activity, phosphatidylinositol 3-kinase, mitogen-activated protein kinase kinase, and p38 mitogen-activated protein kinase. Moreover, overexpressing dominant-negative forms of extracellular signal-regulated kinase 1, c-Jun NH2-terminal kinase, p38, and c-Jun blocked EGF-mediated induction of COX-2 promoter activity. Taken together, these findings suggest that deregulation of the EGF receptor signaling pathway may lead to enhanced COX-2 expression in cervical cancer.


Subject(s)
Adenocarcinoma/enzymology , Carcinoma, Adenosquamous/enzymology , Carcinoma, Squamous Cell/enzymology , Isoenzymes/metabolism , Prostaglandin-Endoperoxide Synthases/metabolism , Sarcoma/enzymology , Uterine Cervical Neoplasms/enzymology , Blotting, Northern , Blotting, Western , Cyclooxygenase 2 , Female , Genes, erbB-1/physiology , Humans , Immunoenzyme Techniques , Isoenzymes/genetics , Membrane Proteins , Mitogen-Activated Protein Kinases/metabolism , Plasmids , Prostaglandin-Endoperoxide Synthases/genetics , RNA, Messenger/metabolism , Signal Transduction , Tumor Cells, Cultured
16.
Am J Physiol Regul Integr Comp Physiol ; 280(1): R132-6, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11124143

ABSTRACT

To determine whether transplanted metanephroi grow, differentiate, and function in hosts that differ in major histocompatibility complex loci (RT1 loci in rats) from donors in a defined way, we implanted metanephroi from embryonic day (E) 15 PVG (RT1(c)) rat embryos into the omentum of nonimmunosupressed uninephrectomized PVG-RT1(avl) (host) rats. By 4 wk posttransplantation, metanephroi had grown and differentiated such that glomeruli, proximal and distal tubules, and collecting ducts had normal structure and ultrastructure. At 12 wk posttransplantation, weights of metanephroi were 54 +/- 8 mg. Inulin clearances were 0.9 +/- 0.3 microl. min(-1). 100 g rat wt(-1). In vitro, splenocytes from PVG rats stimulated the proliferation of cells originating from both PVG-RT1(avl) rats in which a transplant had been performed and PVG-RT1(avl) rats with no transplant. Full-thickness PVG-RT1(avl) skin engrafted normally on PVG-RT1(avl) rats in which PVG metanephroi had been previously implanted and metanephroi retained a normal appearance. In contrast, skin from PVG rats sloughed, and the tubular architecture of metanephroi was obliterated by a mononuclear cell infiltrate consistent with acute rejection. Here we show for the first time that functional chimeric kidneys develop from metanephroi transplanted across the MHC into nonimmunosupressed hosts and provide evidence that a state of peripheral immune tolerance secondary to T cell "ignorance" permits their survival.


Subject(s)
Fetal Tissue Transplantation/immunology , Immune Tolerance/immunology , Kidney Transplantation/immunology , Kidney/embryology , Kidney/immunology , Major Histocompatibility Complex/immunology , Animals , Cell Division , Female , Graft Survival/immunology , Inulin/pharmacokinetics , Kidney/ultrastructure , Microscopy, Electron , Nephrectomy , Omentum/surgery , Rats , Rats, Sprague-Dawley , Skin Transplantation , T-Lymphocytes/immunology
17.
J Urol ; 164(2): 511-7, 2000 Aug.
Article in English | MEDLINE | ID: mdl-10893636

ABSTRACT

PURPOSE: Complete ureteral obstruction (CUTO) in the fetal kidney induces tubular and glomerular cysts, interstitial fibrosis, and halts renal development. Previous studies have shown that apoptosis is a predominant mechanism in the chronically injured kidney following obstruction, but the precise cellular and molecular mechanisms are poorly understood. MATERIALS AND METHODS: We have used CUTO in opossum pups with early metanephric kidneys, sacrificed at two weeks, to evaluate the role of cell proliferation, apoptosis and apoptosis regulating genes, Bcl-2 and Bax. RESULTS: Obstructed fetal kidneys demonstrate high apoptosis in the renal pelvis and tubulointerstitium, compared with sham operated animals. Apoptosis is accompanied by statistically significant increased cell proliferation in the interstitium but not in tubules. Apoptosis in the tubules is accompanied by increased Bax and decreased Bcl-2 staining. In the nephrogenic zone apoptosis is increased, even though it is not statistically significant. Bcl-2 and Bax in the nephrogenic zone are unchanged compared with sham, but cell proliferation is increased. CONCLUSIONS: We suggest that abnormal patterns of cell kinetics may contribute to disease pathogenesis in the obstructed fetal kidney.


Subject(s)
Apoptosis , Cell Division , Kidney/pathology , Proto-Oncogene Proteins c-bcl-2/analysis , Proto-Oncogene Proteins/analysis , Ureteral Obstruction/genetics , Ureteral Obstruction/pathology , Animals , Disease Models, Animal , Immunohistochemistry , In Situ Hybridization , Kidney/chemistry , Microscopy, Electron , Opossums , Ureteral Obstruction/metabolism , bcl-2-Associated X Protein
18.
Am J Physiol Renal Physiol ; 279(1): F130-43, 2000 Jul.
Article in English | MEDLINE | ID: mdl-10894795

ABSTRACT

Unilateral ureteral obstruction (UUO) is a model of renal injury characterized by progressive tubulointerstitial fibrosis and renal damage, while relatively sparing the glomerulus and not producing hypertension or abnormalities in lipid metabolism. Tubulointerstitial fibrosis is a major component of several kidney diseases associated with the progression to end-stage renal failure. Here we report that when a critical renal developmental morphogen, osteogenic protein-1 (OP-1; 100 or 300 microg/kg body wt), is administered at the time of UUO and every other day thereafter, interstitial inflammation and fibrogenesis are prevented, leading to preservation of renal function during the first 5 days after obstruction. Compared with angiotensin-converting enzyme inhibition with enalapril treatment, OP-1 was more effective in preventing tubulointerstitial fibrosis and in preserving renal function. The mechanism of OP-1- induced renal protection was associated with prevention of tubular atrophy, an effect not shared with enalapril, and was related to preservation of tubular epithelial integrity. OP-1 blocked the stimulation of epithelial cell apoptosis produced by UUO, which promoted maintenance of tubular epithelial integrity. OP-1 preserved renal blood flow (RBF) during UUO, but enalapril also stimulated RBF. Thus OP-1 treatment inhibited tubular epithelial disruption stimulated by the renal injury of UUO, preventing tubular atrophy and diminishing the activation of tubulointerstitial inflammation and fibrosis and preserving renal function.


Subject(s)
Bone Morphogenetic Proteins/therapeutic use , Fibrosis/complications , Fibrosis/drug therapy , Kidney/pathology , Transforming Growth Factor beta , Ureteral Obstruction/complications , Actins/metabolism , Angiotensin-Converting Enzyme Inhibitors/pharmacology , Animals , Apoptosis/drug effects , Atrophy/drug therapy , Atrophy/pathology , Bone Morphogenetic Protein 7 , Bone Morphogenetic Proteins/administration & dosage , Bone Morphogenetic Proteins/metabolism , Bone Morphogenetic Proteins/pharmacology , Cell Size/drug effects , Collagen/metabolism , Enalapril/pharmacology , Epithelial Cells/drug effects , Epithelial Cells/metabolism , Epithelial Cells/pathology , Fibrosis/metabolism , Fibrosis/pathology , Immunohistochemistry , Inflammation/complications , Inflammation/drug therapy , Inflammation/immunology , Inflammation/pathology , Kidney/drug effects , Kidney/metabolism , Kidney/physiopathology , Macrophages/drug effects , Macrophages/immunology , Rats , Rats, Sprague-Dawley , Renal Circulation/drug effects
19.
Hum Pathol ; 31(1): 122-5, 2000 Jan.
Article in English | MEDLINE | ID: mdl-10665924

ABSTRACT

mu heavy chain deposition disease is very rare. We report the first case of glomerulonephritis in a woman without evidence of hematopoietic malignancy. Nodular glomerulosclerosis and monotypic mu heavy chain mesangial deposits were identified by immunofluorescence without kappa or lambda deposits. Electron microscopy showed fibrillar mesangial deposits of 16-18 nm in diameter. Serum immunoglobulins, cryoglobulins, serum immunoelectrophoresis, and immunofixation, bone marrow biopsy, and Bence Jones proteins in urine were negative. The patient has stable renal disease and is free of malignancy 6 years after the initial occurrence of proteinuria.


Subject(s)
Glomerulosclerosis, Focal Segmental/etiology , Heavy Chain Disease/complications , Immunoglobulin mu-Chains , Aged , Female , Fluorescent Antibody Technique , Glomerular Mesangium/metabolism , Glomerular Mesangium/pathology , Glomerulosclerosis, Focal Segmental/metabolism , Glomerulosclerosis, Focal Segmental/pathology , Heavy Chain Disease/metabolism , Heavy Chain Disease/pathology , Humans , Microscopy, Electron
SELECTION OF CITATIONS
SEARCH DETAIL
...